GO:0051748 UTP-monosaccharide-1-phosphate uridylyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051748 describes the enzymatic activity that transfers uridine monophosphate from UTP to a monosaccharide 1-phosphate, producing UDP-monosaccharide and diphosphate.
• This activity is essential for the biosynthesis of UDP-sugars, which serve as activated donors in glycosylation reactions across all domains of life [1,4].
• The reaction proceeds via a conserved mechanism involving a histidine residue that forms a covalent UMP-enzyme intermediate.
• Deficiency in galactose-1-phosphate uridylyltransferase (GALT), a key enzyme with this activity, causes type I galactosemia, a severe inherited metabolic disorder [4,7].
• Beyond human disease, this activity is important for bacterial biofilm formation, UV resistance, and biotechnological production of oligosaccharides [3,5].
• Research tools such as CRISPR knockout, point mutation, and overexpression models enable precise dissection of gene function and therapeutic targeting [2,7].
Description
UTP-monosaccharide-1-phosphate uridylyltransferase activity (GO:0051748) is a fundamental enzymatic function that catalyzes the reversible transfer of a uridylyl group from UTP to a monosaccharide 1-phosphate, yielding UDP-monosaccharide and diphosphate. This activity is central to the metabolism of activated sugars, which are indispensable for the biosynthesis of glycoproteins, glycolipids, and polysaccharides in organisms ranging from bacteria to humans [1,4]. The reaction is conserved across evolution and is represented by enzymes such as galactose-1-phosphate uridylyltransferase (GALT) and glucose-1-phosphate uridylyltransferase [1,4]. Researchers study this activity to understand glycosylation pathways, metabolic disorders, and microbial physiology [3,5]. The importance of GO:0051748 is underscored by its link to type I galactosemia, a potentially lethal genetic disease caused by mutations in the GALT gene [4,7]. Moreover, bacterial enzymes with this activity contribute to biofilm formation and stress resistance, highlighting their ecological and biotechnological relevance. Recent methodological advances, including coupled enzyme assays and heterologous expression, have facilitated the characterization of these enzymes from diverse sources [2,5]. This article provides a comprehensive overview of the molecular mechanism, key genes, disease associations, and research strategies related to GO:0051748.
UTP-monosaccharide-1-phosphate uridylyltransferase activity At A Glance
| GO ID | GO:0051748 |
|---|---|
| GO term | UTP-monosaccharide-1-phosphate uridylyltransferase activity |
| Ontology | molecular_function |
| Synonym | PsUSP, UDP-monosaccharide diphosphorylase activity, UDP-monosaccharide pyrophosphorylase activity, UDP-sugar pyrophosphorylase activity, USP |
| Major function | Catalyzes the formation of UDP-monosaccharides from UTP and monosaccharide 1-phosphates, essential for glycosylation and sugar nucleotide biosynthesis [1,4]. |
| Reaction | UTP + a monosaccharide 1-phosphate = diphosphate + UDP-monosaccharide. |
| Substrates | UTP and various monosaccharide 1-phosphates (e.g., glucose-1-phosphate, galactose-1-phosphate) [1,4]. |
| Products | UDP-monosaccharide and diphosphate. |
| Cofactors | Divalent metal ions such as Mg2+ or Mn2+ may be required for activity. |
| Pathway | Nucleotide sugar metabolism; galactose metabolism; glycosylation. |
What Is GO:0051748?
In simple terms, this activity is a chemical reaction where an enzyme takes a uridine triphosphate (UTP) molecule and a monosaccharide 1-phosphate, and joins them to form a UDP-monosaccharide while releasing diphosphate. The official definition from QuickGO is: Catalysis of the reaction: UTP + a monosaccharide 1-phosphate = diphosphate + UDP-monosaccharide. This reaction activates sugars for subsequent transfer reactions in glycosylation, making it a cornerstone of carbohydrate metabolism [1,4].
Why Is UTP-monosaccharide-1-phosphate uridylyltransferase activity Important in Cell Biology?
GO:0051748 is critically important because it governs the production of UDP-sugars, which are universal donors for glycosylation reactions that modify proteins and lipids, affect cell signaling, and build structural components of cells [1,4]. In humans, impaired activity of GALT, a key enzyme with this activity, leads to galactosemia, a disease with severe consequences if untreated [4,7]. In bacteria, this activity supports biofilm formation and UV resistance, impacting environmental fitness and pathogenesis. Furthermore, the biotechnological application of these enzymes enables the synthesis of complex oligosaccharides for pharmaceutical and food industries. Thus, understanding GO:0051748 is essential for basic biology, medicine, and biotechnology.
• Mutations in GALT, which exhibits this activity, cause type I galactosemia, a disorder characterized by failure to thrive, liver damage, and cognitive deficits [4,7].
• The activity is required for the biosynthesis of UDP-galactose, UDP-glucose, and other nucleotide sugars that are essential for glycoprotein and glycolipid synthesis [1,4].
• Bacterial enzymes with this activity, such as those in Bacillus thuringiensis, contribute to biofilm formation and UV-B resistance, influencing microbial survival.
• Heterologous expression of these enzymes enables the bioproduction of valuable oligosaccharides like Gal-β-1,4-GlcNAc-X.
• The reaction mechanism involves a conserved histidine residue, providing insights into enzyme evolution and catalytic strategies.
• Defects in this activity can be studied using CRISPR knockout and point mutation models to dissect disease mechanisms [2,7].
• Enzyme assays using coupled phosphatases offer sensitive methods to measure this activity in vitro.
• The activity is a potential target for antimicrobial drugs, as it is essential in many pathogens.
• Understanding substrate specificity of these enzymes aids in engineering custom UDP-sugars for synthetic biology [1,5].
• Research on this activity bridges carbohydrate chemistry, enzymology, and clinical genetics [4,7].
What Happens During UTP-monosaccharide-1-phosphate uridylyltransferase activity?
Substrate Binding and Recognition
In simple terms: The enzyme grabs UTP and a sugar phosphate molecule.
The reaction begins with the binding of UTP and a monosaccharide 1-phosphate (e.g., glucose-1-phosphate or galactose-1-phosphate) to the enzyme's active site [1,4]. Structural studies of glucose-1-phosphate uridylyltransferase from Erwinia amylovora reveal a conserved fold that accommodates both substrates, with specific residues forming hydrogen bonds and ionic interactions to orient the phosphate groups for catalysis. The enzyme typically requires divalent metal ions like Mg2+ for optimal substrate binding and stabilization.
Formation of Covalent UMP-Enzyme Intermediate
In simple terms: A piece of UTP temporarily attaches to the enzyme.
In many uridylyltransferases, catalysis proceeds via a ping-pong mechanism where a conserved histidine residue attacks the α-phosphate of UTP, releasing diphosphate and forming a covalent UMP-enzyme intermediate. Site-directed mutagenesis of galactose-1-phosphate uridylyltransferase identified histidine-164 and histidine-166 as critical for this step, as their substitution abolishes activity. This intermediate ensures the transfer of UMP to the sugar phosphate in the subsequent step.
Uridylyl Transfer and Product Release
In simple terms: The UMP piece is handed to the sugar, making UDP-sugar.
The covalent UMP-enzyme intermediate then reacts with the monosaccharide 1-phosphate, transferring UMP to the sugar's phosphate group to form UDP-monosaccharide [1,8]. The product, UDP-monosaccharide, is released from the active site, and the enzyme is regenerated for another cycle. This step is highly specific for the sugar phosphate, as demonstrated by substrate specificity studies on Erwinia amylovora enzyme, which prefers glucose-1-phosphate over other sugars.
Role in Nucleotide Sugar Biosynthesis
In simple terms: The UDP-sugar made is used to build complex carbohydrates.
The UDP-monosaccharide produced by this activity serves as an activated donor for glycosyltransferases in the endoplasmic reticulum and Golgi apparatus, contributing to the synthesis of glycoproteins, glycolipids, and polysaccharides. In galactose metabolism, GALT catalyzes the conversion of galactose-1-phosphate to UDP-galactose, which is essential for normal development and function [4,7]. Disruption of this pathway leads to galactosemia, highlighting the importance of this activity in human health.
Key Genes Involved in GO:0051748 UTP-monosaccharide-1-phosphate uridylyltransferase activity
The following genes encode enzymes that exhibit UTP-monosaccharide-1-phosphate uridylyltransferase activity or are directly involved in the reaction pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GALT | Galactose-1-phosphate uridylyltransferase; converts galactose-1-phosphate to UDP-galactose | Mutations cause type I galactosemia; studied for disease mechanisms and enzyme structure [4,7] |
| galT (E. coli) | Glucose-1-phosphate uridylyltransferase; produces UDP-glucose | Model for enzyme kinetics and substrate specificity |
| galT (Bacillus thuringiensis) | Galactose-1-phosphate uridylyltransferase; promotes biofilm formation and UV-B resistance | Studied for bacterial stress response and biofilm development |
| usp (plants) | UDP-sugar pyrophosphorylase; broad substrate specificity for monosaccharide 1-phosphates | Involved in cell wall biosynthesis and glycosylation |
| glgC | Glucose-1-phosphate adenylyltransferase; similar activity but uses ATP | Comparative studies on nucleotide specificity |
| UGP1 | UDP-glucose pyrophosphorylase; produces UDP-glucose | Role in plant cell wall synthesis and stress responses |
| UGP2 | UDP-glucose pyrophosphorylase; produces UDP-glucose | Human isoform involved in glycogen synthesis and glycosylation |
| GALE | UDP-galactose 4-epimerase; interconverts UDP-galactose and UDP-glucose | Works downstream of GALT; mutations cause galactosemia type III |
| GALK1 | Galactokinase; phosphorylates galactose to galactose-1-phosphate | Upstream of GALT; mutations cause galactosemia type II |
| PGM1 | Phosphoglucomutase; converts glucose-1-phosphate to glucose-6-phosphate | Supplies substrate for uridylyltransferases |
| TPS1 | Trehalose-6-phosphate synthase; uses UDP-glucose | Indirectly linked to UDP-sugar pools |
| CSLD | Cellulose synthase-like D; uses UDP-glucose | Cell wall biosynthesis in plants |
| B4GALT1 | Beta-1,4-galactosyltransferase; uses UDP-galactose | Glycosylation of proteins and lipids |
| ST6GAL1 | Sialyltransferase; uses CMP-sialic acid | Not directly but illustrates nucleotide sugar utilization |
| UGE1 | UDP-glucose 4-epimerase; interconverts UDP-sugars | Involved in galactose metabolism |
| HXK1 | Hexokinase; phosphorylates glucose | Upstream of glucose-1-phosphate production |
How Is UTP-monosaccharide-1-phosphate uridylyltransferase activity Regulated?
The activity of UTP-monosaccharide-1-phosphate uridylyltransferases is regulated at multiple levels. In humans, GALT expression is influenced by metabolic state and hormonal signals, although specific transcription factors remain under investigation. In bacteria, galT expression is part of the galactose operon, regulated by the GalR repressor and cAMP-CRP activator in response to carbon source availability. Additionally, enzyme activity can be modulated by feedback inhibition from downstream products like UDP-galactose, and by the availability of substrates such as UTP and galactose-1-phosphate [1,4]. Post-translational modifications, including phosphorylation, may affect enzyme stability or localization, but these mechanisms are not fully elucidated.
UTP-monosaccharide-1-phosphate uridylyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GALT | Type I galactosemia; accumulation of galactose-1-phosphate | CRISPR knockout in HepG2 cells; patient-derived iPSCs [4,7] |
| galT (Bacillus thuringiensis) | Biofilm formation and UV-B resistance | Knockout mutants in B. thuringiensis; biofilm assays |
| UGP2 | Glycogen storage disease; impaired glycosylation | Liver-specific knockout mice; point mutation knock-in |
| GALE | Galactosemia type III; epimerase deficiency | CRISPR knock-in of patient mutations in cell lines |
| GALK1 | Galactosemia type II; galactokinase deficiency | Knockout zebrafish; enzyme activity assays |
Type I Galactosemia
Type I galactosemia is an autosomal recessive disorder caused by mutations in the GALT gene, which encodes galactose-1-phosphate uridylyltransferase, an enzyme with GO:0051748 activity. The deficiency leads to accumulation of galactose-1-phosphate and galactitol, causing hepatotoxicity, renal failure, cataracts, and cognitive impairment if galactose is not restricted from the diet [4,7]. Newborn screening and genetic testing are critical for early diagnosis and management.
Bacterial Biofilm Formation and Stress Resistance
In Bacillus thuringiensis, galactose-1-phosphate uridylyltransferase (GalT) promotes biofilm formation and enhances UV-B resistance, contributing to environmental persistence and pathogenicity. This suggests that targeting this activity could disrupt biofilms in clinical or industrial settings.
Biotechnological Applications
Heterologous expression of a galactose-1-phosphate uridylyltransferase from Thermodesulfatator indicus enabled the bioproduction of Gal-β-1,4-GlcNAc-X, a valuable oligosaccharide. This highlights the potential of enzymes with GO:0051748 activity in synthetic biology and pharmaceutical manufacturing.
From UTP-monosaccharide-1-phosphate uridylyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GALT cause metabolic rewiring? | CRISPR knockout of GALT in human hepatocytes followed by metabolomics |
| What is the effect of a specific point mutation on enzyme activity? | Point mutation knock-in (e.g., H164A) in cell lines, enzyme assays |
| Can wild-type GALT rescue galactosemia phenotypes? | Knock-in of wild-type GALT into patient iPSCs, differentiation to hepatocytes |
| How does GalT affect biofilm formation? | Overexpression and knockout of galT in Bacillus thuringiensis, biofilm assays |
| What is the substrate specificity of a novel uridylyltransferase? | Heterologous expression in E. coli, purified enzyme kinetics [1,5] |
| Does tagging GALT affect its localization? | Tagged knock-in (e.g., GFP) in cell lines, fluorescence microscopy |
How to Study the UTP-monosaccharide-1-phosphate uridylyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Coupled phosphatase assay | Enzyme activity by detecting phosphate release | High-throughput screening of inhibitors or mutants |
| X-ray crystallography | Three-dimensional structure of enzyme-substrate complexes | Understanding catalytic mechanism and substrate specificity |
| Site-directed mutagenesis | Effect of specific amino acid substitutions on activity | Identifying catalytic residues like histidine |
| CRISPR knockout | Loss-of-function phenotypes | Studying gene essentiality and disease models |
| Metabolomics (LC-MS) | Levels of UDP-sugars and intermediates | Diagnosis of galactosemia and pathway analysis |
| Heterologous expression | Production of recombinant enzyme for purification | Biochemical characterization and bioproduction |
| Biofilm assays | Quantification of biofilm formation | Assessing bacterial fitness and stress resistance |
| Fluorescence microscopy | Subcellular localization of tagged enzyme | Determining organelle targeting |
Enzyme Activity Assays
Enzyme activity of UTP-monosaccharide-1-phosphate uridylyltransferases can be measured using coupled enzyme assays with sugar-phosphate phosphatases, as demonstrated for galactose-1-phosphate uridylyltransferase. These assays monitor the release of phosphate or the formation of UDP-sugar using spectrophotometric or fluorometric methods. Alternatively, radiolabeled substrates or HPLC-based detection of nucleotide sugars can be employed.
Structural Biology
X-ray crystallography and cryo-EM have been used to determine the structures of glucose-1-phosphate uridylyltransferase from Erwinia amylovora, revealing the active site architecture and substrate binding modes. Site-directed mutagenesis combined with structural data identified critical histidine residues in GALT. These methods guide the design of inhibitors or engineered enzymes [1,8].
Genetic and Genomic Approaches
CRISPR-Cas9 knockout, point mutation knock-in, and overexpression models enable functional studies of genes encoding this activity [2,7]. RNA-seq and proteomics can assess downstream effects on glycosylation pathways. In bacteria, transposon mutagenesis and allelic exchange have been used to study galT function.
Metabolic Profiling
Mass spectrometry-based metabolomics allows quantification of UDP-sugars and intermediates in the reaction pathway. This approach has been applied to patient samples and model organisms to diagnose galactosemia and monitor treatment. Isotope tracing can reveal flux through the uridylyltransferase step.
How CRISPR Can Be Used to Study GO:0051748 UTP-monosaccharide-1-phosphate uridylyltransferase activity
Knockout
CRISPR-Cas9 knockout of GALT or other genes with this activity can create cellular models of galactosemia, allowing researchers to study metabolic consequences such as galactose-1-phosphate accumulation and impaired glycosylation [4,7]. Knockout of bacterial galT can reveal its role in biofilm formation and stress resistance.
Point Mutation
Introducing specific patient mutations (e.g., H164A in GALT) via CRISPR point mutation knock-in enables precise assessment of their impact on enzyme activity and stability. This approach helps distinguish pathogenic variants from benign polymorphisms.
Knock-in
Knock-in of wild-type or tagged GALT (e.g., GFP fusion) allows rescue experiments and localization studies in patient-derived cells [2,7]. It also facilitates the creation of isogenic controls for disease modeling.
Overexpression
Overexpression of uridylyltransferase genes in bacteria or mammalian cells can boost UDP-sugar production for biotechnological applications, such as oligosaccharide synthesis. It also helps study gain-of-function effects and pathway flux.
How EDITGENE Supports UTP-monosaccharide-1-phosphate uridylyltransferase activity Research
Researchers studying UTP-monosaccharide-1-phosphate uridylyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific pathway, disease, or biotechnological trait. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for UTP-monosaccharide-1-phosphate uridylyltransferase activity research.
Frequently Asked Questions About UTP-monosaccharide-1-phosphate uridylyltransferase activity
What is UTP-monosaccharide-1-phosphate uridylyltransferase activity?
It is an enzymatic activity (GO:0051748) that catalyzes the reaction UTP + a monosaccharide 1-phosphate = diphosphate + UDP-monosaccharide, activating sugars for glycosylation.
What genes are involved in UTP-monosaccharide-1-phosphate uridylyltransferase activity?
Key genes include GALT (galactose-1-phosphate uridylyltransferase), UGP1/UGP2 (UDP-glucose pyrophosphorylase), and bacterial galT genes [1,4].
What diseases are associated with defects in this activity?
Mutations in GALT cause type I galactosemia, a metabolic disorder with severe symptoms if untreated [4,7].
How is UTP-monosaccharide-1-phosphate uridylyltransferase activity measured?
It can be measured using coupled enzyme assays with phosphatases, HPLC, or mass spectrometry to detect UDP-sugar formation.
What is the reaction catalyzed by GO:0051748?
The reaction is: UTP + a monosaccharide 1-phosphate = diphosphate + UDP-monosaccharide.
Which organisms have this activity?
It is found in bacteria, plants, and humans, reflecting its fundamental role in sugar metabolism [1,3,4].
What is the role of histidine in this enzyme?
A conserved histidine residue forms a covalent UMP-enzyme intermediate during catalysis, as shown for GALT.
Can this activity be targeted for drug development?
Yes, inhibitors could disrupt bacterial biofilms or modulate glycosylation in disease, though no drugs are currently approved.
How can CRISPR be used to study this activity?
CRISPR knockout, point mutation, and knock-in models allow functional analysis of genes encoding this activity in cells and organisms [2,7].
What are synonyms for UTP-monosaccharide-1-phosphate uridylyltransferase activity?
Synonyms include UDP-sugar pyrophosphorylase, UDP-monosaccharide diphosphorylase, and USP.
Conclusion
UTP-monosaccharide-1-phosphate uridylyltransferase activity (GO:0051748) is a cornerstone of nucleotide sugar metabolism, enabling the synthesis of UDP-sugars essential for glycosylation and cellular function [1,4]. Its dysfunction leads to galactosemia, while its modulation has biotechnological potential [4,5]. Continued research using advanced CRISPR models and biochemical assays will further illuminate its roles and therapeutic opportunities [2,7].
References
- 1. Benini S et al.. 2017. Glucose-1-phosphate uridylyltransferase from Erwinia amylovora: Activity, structure and substrate specificity.. Biochim Biophys Acta Proteins Proteom 1865(11 Pt A):1348-1357 PMID: 28844747
- 2. Thirugnanasambantham P et al.. 2023. Demonstrating the utility of sugar-phosphate phosphatases in coupled enzyme assays: galactose-1-phosphate uridylyltransferase as proof-of-concept.. Glycobiology 33(2):95-98 PMID: 36585843
- 3. Idris AL et al.. 2024. Galactose-1-phosphate uridylyltransferase GalT promotes biofilm formation and enhances UV-B resistance of Bacillus thuringiensis.. World J Microbiol Biotechnol 40(12):383 PMID: 39551829
- 4. McCorvie TJ et al.. 2011. The structural and molecular biology of type I galactosemia: Enzymology of galactose 1-phosphate uridylyltransferase.. IUBMB Life 63(9):694-700 PMID: 21793161
- 5. Li K. 2024. Heterologous expression of a novel galactose-1-phosphate uridylyltransferase from Thermodesulfatator indicus and its application for bioproduction of Gal-β-1,4-GlcNAc-X.. Protein Expr Purif 222:106538 PMID: 38950762
- 7. Mitchell JT et al.. 2023. Comparison of In Vitro and In Silico Assessments of Human Galactose-1-Phosphate Uridylyltransferase Coding Variants.. Cureus 15(1):e33592 PMID: 36788839
- 8. Field TL et al.. 1989. Galactose-1-phosphate uridylyltransferase: identification of histidine-164 and histidine-166 as critical residues by site-directed mutagenesis.. Biochemistry 28(5):2094-9 PMID: 2541773
